Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2684 |
|
| Actual shortage: | 240 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2435 (91%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
24 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-CEFADROXIL | 500MG | CAPSULE | Resolved | 2021-08-05 | 2021-12-02 | 143716 |
| TEVA-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2021-09-02 | 2021-12-02 | 145106 |
| TEVA-CLOXACILLIN | 250MG | CAPSULE | Resolved | 2021-10-28 | 2021-12-02 | 148424 |
| TEVA-NABILONE | 0.25MG | CAPSULE | Resolved | 2021-11-25 | 2021-12-02 | 149942 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2021-10-21 | 2021-12-08 | 147705 |
| TEVA-CEPHALEXIN 250 | 250MG | POWDER FOR SUSPENSION | Resolved | 2021-10-07 | 2021-12-08 | 146850 |
| TEVA-CYCLOBENZAPRINE | 10MG | TABLET | Resolved | 2021-07-08 | 2021-12-08 | 142195 |
| TEVA-MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-09-09 | 2021-12-08 | 145446 |
| FLUDARABINE PHOSPHATE FOR INJECTION | 25MG | SOLUTION | Resolved | 2021-11-11 | 2021-12-11 | 149108 |
| TEVA-FLUVASTATIN | 20MG | CAPSULE | Resolved | 2021-05-20 | 2021-12-17 | 139731 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2021-10-14 | 2021-12-17 | 147216 |
| TEVA-TOBRAMYCIN | 60MG | SOLUTION | Resolved | 2021-10-14 | 2021-12-17 | 147231 |
| TEVA-ABACAVIR/LAMIVUDINE | 300MG 600MG | TABLET | Resolved | 2021-10-21 | 2021-12-17 | 147699 |
| TEVA-RISEDRONATE | 30MG | TABLET | Resolved | 2021-10-21 | 2021-12-17 | 147714 |
| TEVA-RASAGILINE | 1MG | TABLET | Resolved | 2021-12-17 | 2021-12-22 | 151445 |
| ACT PRAMIPEXOLE | 0.5MG | TABLET | Resolved | 2021-11-18 | 2021-12-23 | 149588 |
| TEVA-TRAZODONE | 50MG | TABLET | Resolved | 2021-11-25 | 2021-12-23 | 149945 |
| TEVA-PREGABALIN | 225MG | CAPSULE | Resolved | 2021-12-17 | 2021-12-23 | 151459 |
| TEVA-TRAZODONE | 50MG | TABLET | Resolved | 2021-12-17 | 2021-12-23 | 151471 |
| TEVA-AMITRIPTYLINE | 25MG | TABLET | Resolved | 2021-06-24 | 2022-01-07 | 141466 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157428 |
| TEVA-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157431 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157434 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157437 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
| CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Discontinued | 2023-11-27 | 2023-11-27 | 211558 |
| TEVA-ECTOSONE | 0.1% | LOTION | Discontinued | 2023-12-05 | 2023-12-05 | 212526 |
| TEVA-DICLOFENAC EC | 25MG | TABLET (ENTERIC-COATED) | Discontinued | 2024-01-25 | 2024-01-26 | 217254 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |